Volume 10 Number 1 2026
Modifiable Triggers and Autoimmune Disease Flares: A Mechanistic and Clinical Synthesis of Molecular Mimicry, Barrier Disruption, and Neuroendocrine-Microbial Crosstalk
Rabiatul Basria S. M. N. Mydin1* Lee Wei Zheng1,2, , Adam Azlan1,3
Integrative Biomedical Research 10 (1) 1-8 https://doi.org/10.25163/biomedical.10110914
Submitted: 15 May 2026 Revised: 10 July 2026 Accepted: 16 July 2026 Published: 18 July 2026
Autoimmune diseases rarely announce themselves through genetics alone; more often, they seem to wait for the right combination of circumstances before they declare themselves clinically. That, at least, is the pattern that emerges once the literature on environmental triggering is read as a whole rather than in fragments. This review set out to ask a fairly simple question with a complicated answer: which modifiable exposures push a genetically susceptible person from quiet predisposition into an active flare, and through what biological routes do they do so? Drawing on a structured, literature search of peer-reviewed sources published mainly between 2014 and 2026, we synthesized evidence spanning viral immunopathogenesis, airborne and disaster-related toxicant exposure, chronic psychological stress acting through the hypothalamic-pituitary-adrenal (HPA) axis, and gut-organ metabolic signaling, alongside emerging artificial-intelligence-based diagnostic frameworks. Several threads recur with a consistency that is hard to dismiss as coincidence. Enteroviral and herpesviral molecular mimicry, most clearly illustrated by Coxsackievirus B4-GAD65 homology in type 1 diabetes mellitus (T1DM) and Epstein-Barr virus EBNA-1 cross-reactivity with myelin proteins in multiple sclerosis (MS), converges mechanistically with airborne pollutant-driven Toll-like receptor and NLRP3 inflammasome activation, with HPA-axis dysregulation and glucocorticoid receptor resistance, and with Western-diet-induced gut dysbiosis and short-chain fatty acid depletion, on a shared downstream endpoint: a tilted T helper 17 (Th17) to regulatory T cell (Treg) balance and a breach of epithelial and mucosal barrier integrity. Vitamin D emerged repeatedly as a connective immunomodulatory thread linking several of these pathways together. None of these exposures appears sufficient in isolation; the evidence instead favors a cumulative, threshold-based model in which concurrent or sequential hits progressively lower the margin required to precipitate clinical disease activity, a pattern we have represented schematically for the reader. Advanced computational tools, including fuzzy-logic expert systems, genetic algorithm-optimized neural networks, and gut-microbiome-based machine learning classifiers, are beginning to translate this complexity into workable, patient-specific prediction tools, though external validation across diverse populations remains limited. We conclude that autoimmune flare risk is best understood not as a single-hit event but as a dynamic, multi-system convergence, and that future clinical strategy should probably move toward precision environmental and nutritional risk mitigation rather than genetic risk alone.
Keywords: autoimmune disease flares; environmental triggers; molecular mimicry; gut-organ axis; HPA axis dysregulation; epithelial barrier hypothesis; precision immunology
Aarnisalo, J., Veijola, R., Vainionpää, R., Simell, O., Knip, M., & Ilonen, J. (2008). Cytomegalovirus infection in early infancy: Risk of induction and progression of autoimmunity associated with type 1 diabetes. Diabetologia, 51(5), 769–772.
Alonso-Bernáldez, M., Higuera-Gómez, A., Martínez-Urbistondo, M., Cuevas-Sierra, A., de Cuevillas, B., De la Cruz-Mosso, U., Nicoletti, C. F., da Mota, J. C. N. L., Mellor-Pita, S., Vizmanos, B., & Martínez, J. A. (2026). Polygenic risk and linked metabolic profile in systemic lupus erythematosus: Cross-sectional insights. Genes, 17(1), 53.
Aminu, A., & Wang, Z. (2026). Targeted delivery of specialized pro-resolving mediators (SPMs) for improved treatments of inflammatory diseases and cancer. Pharmaceutics, 18(8), 1048.
Asamoah, A., & Ahima, R. S. (2026). Overview of clinical genetics of diabetes mellitus. Genes, 17(2), 215.
Borgonovo, R., Nespoli, L. M., Ceroni, M., Arnaud, L. M., Morellini, L., Lissi, M., & Sacco, L. (2025). Potential genetic intersections between ADHD and Alzheimer's disease: A systematic review. NeuroSci, 6(4), 97.
Borkowska, A., Jaskiewicz, L., Kowalska, A., Chmielewski, G., & Kowalska-Wojtosek, M. (2026). The role of neuroinflammation and the HPA axis in rheumatoid arthritis fatigue. Journal of Clinical Medicine, 15(17), 6559.
Brozek, R., Lorenz, A., Dorocka-Bobkowska, B., & Kurpisz, M. (2026). Advanced biological therapies: Principles, mechanisms and medical applications. Journal of Clinical Medicine, 15(6), 6523.
Cichocka, E., Maj-Podsiadlo, A., Górczynska-Kosiorz, S. B., Szweda-Gandor, N., & Gumprecht, J. (2025). Interaction between CTLA-4, FOXO-3, and PTPN-22 variants and environmental factors in type 1 diabetes—Observational association study. Nutrients, 17(24), 3886.
Cinek, O., Witsø, E., Jeansson, S., Vasuka, A., Dewals, M., & Ronningen, K. S. (2005). Longitudinal monitoring of enterovirus and adenovirus in feces of Norwegian infants at high genetic risk of type 1 diabetes. Journal of Medical Virology, 75(4), 567–575.
Curto, A., Scami, I., Gliottone, G., Iamello, R. G., Lynch, E. N., & Galli, A. (2026). Autoimmune hepatitis: Emerging frontiers in research and clinical management. Gastrointestinal Disorders, 8(1), 20–37.
Czerewaty, M., Dec, P., Safranow, K., & Pawlik, A. (2026). Long non-coding RNAs SNHG7, SNHG12, and SNHG14 in rheumatoid arthritis: Clinical and in silico analysis. Current Issues in Molecular Biology, 48(8), 860.
Ekman, I., Vuorinen, T., Knip, M., Veijola, R., Toppari, J., Hyöty, H., Kinnunen, T., Ilonen, J., & Lempainen, J. (2018). Early childhood CMV infection may decelerate the progression to clinical type 1 diabetes. Pediatric Diabetes, 20(1), 73–77.
Frohman, D. F. T., & Tsirka, S. E. (2026). Infectious agents in multiple sclerosis: Viral triggers, antibody-mediated autoimmunity, and parasitic immunomodulation. Biomolecules, 16(5), 899–912.
Gutierrez Nunez, S. G., Rabelo, S. P., Subotic, N., Caruso, J. W., & Knezevic, N. N. (2025). Chronic stress and autoimmunity: The role of HPA axis and cortisol dysregulation. International Journal of Molecular Sciences, 26(20), 9994.
Italian Society of Gerontology and Geriatrics [JGG]. (2026). Assessment of causes and potential prevention and therapy for autoimmune diseases through evolutionary medicine. Journal of Gerontology and Geriatrics, 74(1), 19–42.
Izzo, O., Gotelli, E., Hysa, E., Campitiello, R., Paolino, S., Pizzorni, C., Soldano, S., Sulli, A., Smith, V., & Cutolo, M. (2026). Effects of vitamin D on epigenetics, seasonality, and management of rheumatoid arthritis. Nutrients, 18(2), 2359.
Kotsiri, I., Xanthi, M., Domazinaki, C.-M., & Magiorkinis, E. (2025). The role of viral infections in the immunopathogenesis of type 1 diabetes mellitus: A narrative review. Biology, 14(8), 981.
Mak, A., & Tay, S. H. (2014). Environmental factors, toxicants and systemic lupus erythematosus. International Journal of Molecular Sciences, 15(9), 16043–16056.
Makkar, D., & Morris, J. (2026). Bridging pathogenesis and precision therapy: Immunoengineering advancements in rheumatoid arthritis management. Rheumato, 6(1), 12.
Mittal, R., Sinha, P., Jhanvi, D., Goldmann, R., Mittal, M., Chaudhary, N., Ravindra, V., & Hirani, K. (2026). The gut–pancreas axis in type 1 diabetes: Emerging insights into microbiota and immune interactions. International Journal of Molecular Sciences, 27(11), 4789.
Mpakosi, A., Cholevas, V., Tzouvelekis, I., Passos, I., Kaliouli-Antonopoulou, C., & Mironidou-Tzouveleki, M. (2024). Autoimmune diseases following environmental disasters: A narrative review of the literature. Healthcare, 12(17), 1767.
Ponce de León-Sánchez, E. R., Mendiola-Santibañez, J. D., Domínguez-Ramírez, O. A., Herrera-Navarro, A. M., Vázquez-Cervantes, A., Jiménez-Hernández, H., Acuña-García, J. A., Duarte-Pérez, R., & Álvarez-Alvarado, J. M. (2026). Artificial intelligence algorithm based on genetics to predict responses to interferon-beta treatment in multiple sclerosis patients. Bioengineering, 13(5), 523.
Predescu, O. R., Vreju, F. A., Dinescu, S. C., Bita, C. E., Musetescu, A. E., Florescu, A., & Ciurea, P. L. (2025). Vitamin D as an immune modulator in systemic lupus erythematosus: A narrative review. Life, 15(10), 1580.
Rigante, D., Fastiggi, M., Guerriero, C., & Candelli, M. (2026). Idiopathic Raynaud's phenomenon and vitamin D deficiency in children and adolescents: An exploratory single-center retrospective observational study throughout the period 2010–2025. Journal of Clinical Medicine, 15(6), 6516.
Rodziewicz, A., & Bryl, E. (2026). The role of microbiome and diet on disease activity and immune-inflammatory status in rheumatoid arthritis. Nutrients, 18(1), 1325.
Santibáñez, N. B., Hely, S., John, S., Arun, K., Joy Raveendran, N., Rishitha, G., Kumar, S. S., Nair, K. A., Pal, S., Sunilkumar, D., & Nair, B. G. (2026). Machine learning applications on the gut microbiome for screening chronic non-communicable and autoimmune diseases. Microorganisms, 14(9), 1880.
Sasidharan, N. B., Hely, S., John, S., Arun, K., Joy Raveendran, N., Rishitha, G., Kumar, S. S., Nair, K. A., Pal, S., Sunilkumar, D., & Nair, B. G. (2026). Postbiotics as multifunctional bioactives: Mechanistic insights and translational applications in host physiology and microbial ecosystem modulation. Microorganisms, 14(12), 1230.
Steri, M., Testori, A., Orrù, V., & Zoledziewska, M. (2026). Type 1 diabetes and multiple sclerosis share general autoimmunity genetic variation. Genes, 17(5), 531.
Szili, K., Dézsi, C., Gulyás-Oldal, V., Sallai, D., Patay, G., Paschali, E., & Nagy, S. (2026). Toward AI-driven detection of asymptomatic chronic conditions from stool metagenomics and dietary data: A multimodal deep learning framework for T1DM, T2DM, MOS/PCOS, cancer, and autoimmune disease. Microorganisms, 14(1), 1880.
Triggianese, P., Ramirez, G. A., Cedola, F., Nicola, S., Costanzo, G., Brussino, L., Chiereghin, F., Firinu, D., Della-Morte, D., & Patella, V. (2026). Micronutrients in autoimmune diseases: Shining a light on vitamin D, cobalamin, folate, and iron metabolism. Nutrients, 18(5), 561.
Wu, D., Tang, L., Ma, Q., Zhou, Z., Wu, Y., Fu, J., Xu, H., Chen, Q., Chen, H., Wang, F., Zhang, Q., Zhang, Q., & Qiu, L. (2026). Identification of cellular senescence-related hub genes in rheumatoid arthritis from bioinformatics analysis through machine learning up to verifications in mouse macrophages and tests in patients. International Journal of Molecular Sciences, 27(16), 7493.